Richard Ronald's Form 4 filing
Emergent BioSolutions Inc. (EBS) · filed Dec 9, 2025
- Accession no.
- 0001380177-25-000006
- Filed
- Dec 9, 2025
- Trade date
- Dec 5, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $263.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Richard RonaldCIK 0001380177 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | Common Stock | SSaleDisposed | −7,100 | $12.11F2 | −$85,981 | 98,417 | Direct | |
| Dec 5, 2025 | Common Stock | MOption exerciseAcquired | +25,748 | $5.02 | +$129,254.96 | 124,165 | Direct | |
| Dec 5, 2025 | Common Stock | FTax withholdingDisposed | −10,864 | $11.90F4 | −$129,281.6 | 113,301 | Direct | |
| Dec 5, 2025 | Common Stock | SSaleDisposed | −14,884 | $11.90F4 | −$177,119.6 | 98,417 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | Common Stock | MOption exerciseDisposed | −25,748 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $12.11 to $12.12.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $11.88 to $11.97.
Referenced by the price of 2 transactions in Table I.